The World Health Organization recommended against using the biotechnology company's remdesivir for hospitalized COVID-19 patients.
News
- Post Holdings, Gilead Sciences fall; Pfizer, Hibbett rise
- Global foundation awards Texas Biomed $1 million to conduct large-scale rodent testing of human ...
Newswise — San Antonio, Texas (Nov. 19, 2020) – Texas Biomedical Research Institute (Texas Biomed) in San Antonio, Texas, was awarded $1 ...
- Journal Article Reviews Oleandrin's Antiviral Activity Against 'Enveloped' Viruses, Including its ...
SAN ANTONIO, Texas--(BUSINESS WIRE)-- In an article, “Antiviral Effects of ... by Phoenix Biotechnology, Inc. (www.phoenixbiotechnology.com).
- Bexar County vaccine distribution plan ready, Metro Health says
SAN ANTONIO - Governor Greg Abbott says Texas is ready to get a COVID vaccine out to you. ... related to science to talk about freezers," said Dr. Joanne Turner, vice president of research at Texas Biomedical Research Institute.
- INVO Bioscience, Inc. (INVO) CEO Steven Shum on Q3 2020 Results - Earnings Call Transcript
INVO Bioscience, Inc. (OTCQB:INVO) Q3 2020 Results Conference Call ... Thank you all for joining us today during INVO Bioscience's third quarter 2020 ... and began offering this to his patients in clinics in San Antonio and Austin, ...